Copayment rates outpace inflation














Workers are definitely paying more for health benefits today than they were in 2000, according to a report from the Employee Benefit Research Institute titled “The Future of Employment-Based Health Benefits: Have Employers Reached a Tipping Point?”

Nowhere is that more evident than in a review of prescription drug copayments, which have been ?out- pacing inflation at a fast clip. The Consumer Price Index between 2000 and 2006 increased by 17 percent. During that period, the average copayment for branded drugs on the formulary increased 85 percent, from $13 to $24. The average copayment for nonpreferred branded drugs increased a hefty 124 percent. And it’s not just brand name drugs experiencing the mark up — the average copayment for generic drugs also increased faster than inflation, up 57 percent between 2000 and 2006. What has dropped during this time, despite the sharp increase in copayment levels, is the percentage of consumer health care expenses paid out of pocket, which is at an all time low.

Average copayment for prescription drugs, 2000–2006

Source: Kaiser Family Foundation

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.

UP NEXT

Managed Care
By Peter Wehrwein
Managed Care
By Howard Wolinsky